Spandidos Publications style
Gazzerro P, Malfitano AM, Proto MC, Santoro A, Pisanti S, Caruso MG, Notarnicola M, Messa C, Laezza C, Misso G, Misso G, et al: Synergistic inhibition of human colon cancer cell growth by the cannabinoid CB1 receptor antagonist rimonabant and oxaliplatin. Oncol Rep 23: 171-175, 2010.
APA
Gazzerro, P., Malfitano, A.M., Proto, M.C., Santoro, A., Pisanti, S., Caruso, M.G. ... Bifulco, M. (2010). Synergistic inhibition of human colon cancer cell growth by the cannabinoid CB1 receptor antagonist rimonabant and oxaliplatin. Oncology Reports, 23, 171-175. https://doi.org/10.3892/or_00000619
MLA
Gazzerro, P., Malfitano, A. M., Proto, M. C., Santoro, A., Pisanti, S., Caruso, M. G., Notarnicola, M., Messa, C., Laezza, C., Misso, G., Caraglia, M., Bifulco, M."Synergistic inhibition of human colon cancer cell growth by the cannabinoid CB1 receptor antagonist rimonabant and oxaliplatin". Oncology Reports 23.1 (2010): 171-175.
Chicago
Gazzerro, P., Malfitano, A. M., Proto, M. C., Santoro, A., Pisanti, S., Caruso, M. G., Notarnicola, M., Messa, C., Laezza, C., Misso, G., Caraglia, M., Bifulco, M."Synergistic inhibition of human colon cancer cell growth by the cannabinoid CB1 receptor antagonist rimonabant and oxaliplatin". Oncology Reports 23, no. 1 (2010): 171-175. https://doi.org/10.3892/or_00000619
